Skip to main content
. 2022 Feb 14;12:2427. doi: 10.1038/s41598-022-06449-4

Figure 1.

Figure 1

Phenotypic overview of the MTB isolates. This bar chart shows numbers of susceptible and resistant isolates with DST results available for each of the four first-line drugs.